$12M CEO Buy. Mixed Signals Everywhere.
CEO Mark Bertolini just dropped $11.9 million on Oscar Health at $11.92 per share. That's serious skin in the game from the top. Problem is the technicals are all over the map right now. Short-term momentum says buy, but medium and long-term trends are pointing south. Worth noting that insiders on this name have struggled historically, with only a 12% win rate at 90 days.
The Filing
| Ticker | OSCR |
| Company | Oscar Health, Inc. |
| Insider | Mark Bertolini, Chief Executive Officer |
| Buy amount | $11.9M |
| Filing date | April 7, 2026 |
| Conviction | Interesting · 56/100 |
| Setup type | Accumulation |
Ultimate members received this analysis in real time.